Belimumab patient profile in Spain: evolution during the last decade and future directions
{{output}}
Introduction: Belimumab (BEL), an anti B-lymphocyte stimulator monoclonal antibody, is the only approved biological therapy for systemic lupus erythematosus (SLE) and lupus nephritis (LN). ... ...
